Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites - OncoDaily Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites / Advanced Breast Cancer, advanced cancer, advanced colorectal cancer, Advanced

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

oncodaily.com/science/bisp...

#AdvancedBreastCancer #ColorectalCancer #M701 #GastricCancer #LungCancer #OvarianCancer #Antibody #ASCO24 #BispecificAntibody #Catumaxomab #EpCAM #ESMO #Immunotherapy#TargetedOncology